Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
BIOMARKER:
EGFR G719X
i
Other names:
EGFR, ERBB, ERBB1, Epidermal growth factor receptor
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Entrez ID:
1956
Related biomarkers:
Expression
Mutation
CNA
Fusion
Others
‹
EGFR exon 19 deletion + EGFR T790M (10)
EGFR mutation + PD-L1 overexpression (8)
MET amplification + EGFR mutation (8)
EGFR exon 19 deletion + PD-L1 overexpression (5)
EGFR mutation + MET amplification (5)
EGFR mutation + PD-L1 expression (5)
EGFR exon 19 deletion + EGFR L643V (4)
EGFR exon 19 deletion + EGFR T790M + EGFR C797S + CTNNB1 exon 3 mutation (4)
PD-L1 expression + EGFR mutation (4)
TA-MUC1 elevation + EGFR expression (4)
TNFRSF10A overexpression + EGFR mutation (4)
EGFR exon 19 deletion + EGFR G724S (3)
EGFR exon 19 deletion + NRAS Q61K (3)
EGFR exon 19 deletion + PTEN K237Cfs*17 (3)
EGFR mutation + ANKRD1 overexpression (3)
EGFR mutation + EGFR amplification (3)
EGFR mutation + MET overexpression (3)
EGFR wild-type + ALK wild-type + PD-L1 expression (3)
MET overexpression + EGFR mutation (3)
AXL expression + EGFR mutation (2)
EGFR C797S + EGFR T790M + EGFR exon 19 deletion + TMB-L (2)
EGFR L858R + EGFR exon 19 deletion (2)
EGFR L858R + PD-L1 overexpression (2)
EGFR L858R + VOPP1-EGFR fusion + EGFR T790M (2)
EGFR exon 19 deletion + MET amplification (2)
EGFR exon 19 deletion + EGFR K754E (2)
EGFR exon 19 deletion + EGFR L861Q + EGFR G873E (2)
EGFR exon 19 deletion + KRAS mutation (2)
EGFR exon 19 deletion + PD-L1 expression (2)
EGFR exon 19 deletion + TP53 mutation + RB1 mutation (2)
EGFR exon 20 insertion + EGFR amplification (2)
EGFR mutation + BCL2L11 deletion (2)
EGFR mutation + CDCA3 underexpression (2)
EGFR mutation + PTEN deletion (2)
EGFR mutation + RET fusion (2)
EGFR mutation + YAP1 overexpression (2)
EGFR mutation + YES1 overexpression (2)
EGFR-SEPTIN14 fusion + EGFR amplification (2)
EGFR exon 19 deletion + MET Amplification + MET D1228V (2)
EML4-ALK gene fusion + EGFR exon 19 deletion + EGFR T790M + EGFR C797G (2)
ERBB3 mutation + TMB-H (2)
HER-2 amplification + EGFR-ZNF880 fusion + EGFR E114K (2)
PD-L1 overexpression + EGFR mutation (2)
TMB-H + EGFR exon 19 deletion (2)
TMB-H + EGFR mutation (2)
ALK fusion + EGFR exon 19 deletion + BRAF G466V + MAP2K1 F129L (1)
APC V2194fs + EGFR amplification + EGFR-SEPTIN14 fusion (1)
APOA1 elevation + EGFR T790M (1)
ARID1A underexpression + EGFR mutation (1)
ATM expression + ATM T2333fs* + EGFR negative (1)
AXL overexpression + EGFR mutation (1)
AXL underexpression + EGFR mutation (1)
BCL2L11 deletion + EGFR T790M (1)
BRAF V600E + EGFR expression (1)
CCDC6-RET fusion + EGFR mutation (1)
CD276 underexpression + EGFR mutation (1)
CD74-NRG1 fusion + EGFR mutation + HER-2 mutation (1)
CRKL overexpression + EGFR mutation (1)
EGFR C797S + KRAS amplification + RB1 deletion (1)
EGFR C797S + MET amplification (1)
EGFR E746_A750del + KRAS amplification (1)
EGFR G719A + EGFR S768I + PD-L1 overexpression (1)
EGFR G719A + PD-L1 overexpression (1)
EGFR G719D + EGFR L861Q + CUX1-MET fusion (1)
EGFR L747P + PD-L1 overexpression (1)
EGFR L747_A750delinsP + MET D1228H + MET D1228N + MET D1228Y + MET Y1230H + MET amplification (1)
EGFR L858R + HER-2 amplification + PIK3CA overexpression (1)
EGFR L858R + KDR overexpression + VEGFC overexpression (1)
EGFR L858R + KRAS amplification + RB1 deletion (1)
EGFR L858R + MET amplification (1)
EGFR L858R + MET overexpression (1)
EGFR L858R + MET positive (1)
EGFR L858R + PD-L1 expression (1)
EGFR L858R + PD-L1 underexpression (1)
EGFR L858R + ROS1 fusion (1)
EGFR L858R + ROS1-ADGRG6 fusion (1)
EGFR L858R + TMB-H (1)
EGFR L858R + VEGFA-L (1)
EGFR P719A + PD-L1 overexpression (1)
EGFR T263P + EGFR L858R + MET amplification (1)
EGFR T790M + HER-2 amplification (1)
EGFR T790M + KRAS amplification + RB1 deletion (1)
EGFR T790M + MET amplification (1)
EGFR T790M + MET positive (1)
EGFR T790M + MYC amplification (1)
EGFR T790M + STRN-ALK fusion + EGFR amplification + MET amplification (1)
EGFR T790M + TMB-H (1)
EGFR V843I + KRAS G13D + AKT1 E17K + PD-L1 overexpression (1)
EGFR exon 19 deletion + ALK amplification (1)
EGFR exon 19 deletion + BRAF G464A (1)
EGFR exon 19 deletion + CCND1 overexpression (1)
EGFR exon 19 deletion + EGFR L747S (1)
EGFR exon 19 deletion + EGFR S768I (1)
EGFR exon 19 deletion + EGFR T790M + EGFR C797S + HER-2 amplification (1)
EGFR exon 19 deletion + EGFR T790M + PD-L1 expression (1)
EGFR exon 19 deletion + EGFR exon 21 mutation + TP53 mutation (1)
EGFR exon 19 deletion + LMNA-NTRK1 fusion + EGFR T790M (1)
EGFR exon 19 deletion + MET positive (1)
EGFR exon 19 deletion + MET amplification (1)
EGFR exon 19 deletion + MET amplification + MET D1228H + MET D1228N + MET D1228Y (1)
EGFR exon 19 deletion + MET amplification + MET D1228H + MET D1228N + MET D1228Y + MET Y1230C (1)
EGFR exon 19 deletion + PD-L1 underexpression (1)
EGFR exon 19 deletion + PTEN deletion + PIK3CA overexpression (1)
EGFR exon 19 deletion + RBM10 S167* (1)
EGFR exon 19 deletion + STRN-ALK fusion (1)
EGFR exon 19 deletion + TP53 mutation + CDK6 amplification + KRAS amplification (1)
EGFR exon 19 deletion + TP53 mutation + MET amplification (1)
EGFR exon 19 deletion + VEGFA-L (1)
EGFR exon 20 insertion + PD-L1 overexpression (1)
EGFR exon 20 insertion + TP53 mutation (1)
EGFR expression + KRAS G12C (1)
EGFR expression + TP53 mutation (1)
EGFR fusion + PD-L1 overexpression (1)
EGFR mutation + ALK negative + TMB-H (1)
EGFR mutation + BCL2L11 overexpression (1)
EGFR mutation + BRCA1 overexpression (1)
EGFR mutation + BRCA1 underexpression (1)
EGFR mutation + CCND1 expression + CDKN2A deletion (1)
EGFR mutation + CD73 overexpression (1)
EGFR mutation + Chr 14q31.1-q31.3 (1)
EGFR mutation + Chr 1p13.3-p13.1 (1)
EGFR mutation + EGFR amplification + MET amplification + MTAP deletion (1)
EGFR mutation + ER positive (1)
EGFR mutation + LANCL2 overexpression (1)
EGFR mutation + LINC00460 overexpression (1)
EGFR mutation + MET amplification + EGFR amplification (1)
EGFR mutation + MET amplification + TP53 mutation (1)
EGFR mutation + MET overexpression + MET amplification (1)
EGFR mutation + MET-CEP7 fusion (1)
EGFR mutation + PD-L1 elevation (1)
EGFR mutation + PD-L1 expression + TP53 mutation (1)
EGFR mutation + PD-L1 negative (1)
EGFR mutation + RBBP8 underexpression (1)
EGFR mutation + ROMO1 overexpression (1)
EGFR mutation + RPS6KB1 amplification (1)
EGFR mutation + S100A9 overexpression (1)
EGFR mutation + SYK overexpression (1)
EGFR mutation + TP53 expression (1)
EGFR mutation + TSLP underexpression (1)
EGFR mutation + TTF1 negative (1)
EGFR mutation + WNT5A expression (1)
EGFR negative + ALK negative + PD-L1 expression (1)
EGFR negative + S100A8 elevation (1)
EGFR negative + S100A9 elevation (1)
EGFR negative + SAA1 elevation (1)
EGFR negative + SAA2 elevation (1)
EGFR overexpression + BRAF V600E (1)
EGFR overexpression + BRAF mutation (1)
EGFR overexpression + KRAS 13D (1)
EGFR overexpression + KRAS mutation (1)
EGFR wild-type + ALK wild-type + NT5E overexpression + PD-L1 expression (1)
EGFR wild-type + Chr 11p11.11-q12.1 (1)
EGFR wild-type + Chr 7q31.1-q31.31 (1)
EGFR wild-type + Chr 9q21.31-q22.2 (1)
EGFR wild-type + MET amplification (1)
EGFR wild-type + MET overexpression (1)
EGFR-SEC61G fusion + EGFR amplification (1)
EGFRvIII mutation + EGFR-SEPTIN14 fusion + EGFR amplification (1)
EPHA2 expression + EGFR mutation (1)
ERCC2 positive + SYP negative + EGFR exon 21 mutation (1)
GPRC6A-RET fusion + EGFR mutation (1)
HER-2 amplification + EGFR mutation (1)
HR negative + EGFR amplification (1)
KIF5B-RET fusion + EGFR exon 19 deletion (1)
KRAS mutation + EGFR amplification (1)
MET exon 14 mutation + EGFR wild-type (1)
MET negative + EGFR mutation (1)
MET overexpression + EGFR wild-type (1)
MET positive + EGFR mutation (1)
NOTCH2-NTRK1 fusion + EGFR L858R (1)
PD-L1 underexpression + EGFR mutation (1)
PTGS2 positive + MET positive + PBK positive + EGFR mutation (1)
RBM10 deletion + EGFR mutation (1)
RBM10 underexpression + EGFR mutation (1)
ROS1 translocation + EGFR wild-type (1)
SHTN1-RET fusion + EGFR mutation (1)
SPECC1-RET fusion + EGFR mutation (1)
STRN-ALK fusion + EML4-ALK fusion + EGFR T790M (1)
TERT mutation + EGFR T790M + EGFR exon 20 insertion (1)
TLN1-RET fusion + EGFR mutation (1)
TRIM24-RET fusion + EGFR mutation (1)
TRIM33-RET fusion + EGFR mutation (1)
CALR elevation + EGFR mutation (0)
HER-2 positive + FGFR1 amplification (0)
PD-L1 underexpression + EGFR wild-type (0)
EGFR exon 19 deletion + EGFR T790M (10)
EGFR mutation + PD-L1 overexpression (8)
MET amplification + EGFR mutation (8)
EGFR exon 19 deletion + PD-L1 overexpression (5)
EGFR mutation + MET amplification (5)
EGFR mutation + PD-L1 expression (5)
EGFR exon 19 deletion + EGFR L643V (4)
EGFR exon 19 deletion + EGFR T790M + EGFR C797S + CTNNB1 exon 3 mutation (4)
PD-L1 expression + EGFR mutation (4)
TA-MUC1 elevation + EGFR expression (4)
TNFRSF10A overexpression + EGFR mutation (4)
EGFR exon 19 deletion + EGFR G724S (3)
EGFR exon 19 deletion + NRAS Q61K (3)
EGFR exon 19 deletion + PTEN K237Cfs*17 (3)
EGFR mutation + ANKRD1 overexpression (3)
EGFR mutation + EGFR amplification (3)
EGFR mutation + MET overexpression (3)
EGFR wild-type + ALK wild-type + PD-L1 expression (3)
MET overexpression + EGFR mutation (3)
AXL expression + EGFR mutation (2)
EGFR C797S + EGFR T790M + EGFR exon 19 deletion + TMB-L (2)
EGFR L858R + EGFR exon 19 deletion (2)
EGFR L858R + PD-L1 overexpression (2)
EGFR L858R + VOPP1-EGFR fusion + EGFR T790M (2)
EGFR exon 19 deletion + MET amplification (2)
EGFR exon 19 deletion + EGFR K754E (2)
EGFR exon 19 deletion + EGFR L861Q + EGFR G873E (2)
EGFR exon 19 deletion + KRAS mutation (2)
EGFR exon 19 deletion + PD-L1 expression (2)
EGFR exon 19 deletion + TP53 mutation + RB1 mutation (2)
EGFR exon 20 insertion + EGFR amplification (2)
EGFR mutation + BCL2L11 deletion (2)
EGFR mutation + CDCA3 underexpression (2)
EGFR mutation + PTEN deletion (2)
EGFR mutation + RET fusion (2)
EGFR mutation + YAP1 overexpression (2)
EGFR mutation + YES1 overexpression (2)
EGFR-SEPTIN14 fusion + EGFR amplification (2)
EGFR exon 19 deletion + MET Amplification + MET D1228V (2)
EML4-ALK gene fusion + EGFR exon 19 deletion + EGFR T790M + EGFR C797G (2)
ERBB3 mutation + TMB-H (2)
HER-2 amplification + EGFR-ZNF880 fusion + EGFR E114K (2)
PD-L1 overexpression + EGFR mutation (2)
TMB-H + EGFR exon 19 deletion (2)
TMB-H + EGFR mutation (2)
ALK fusion + EGFR exon 19 deletion + BRAF G466V + MAP2K1 F129L (1)
APC V2194fs + EGFR amplification + EGFR-SEPTIN14 fusion (1)
APOA1 elevation + EGFR T790M (1)
ARID1A underexpression + EGFR mutation (1)
ATM expression + ATM T2333fs* + EGFR negative (1)
AXL overexpression + EGFR mutation (1)
AXL underexpression + EGFR mutation (1)
BCL2L11 deletion + EGFR T790M (1)
BRAF V600E + EGFR expression (1)
CCDC6-RET fusion + EGFR mutation (1)
CD276 underexpression + EGFR mutation (1)
CD74-NRG1 fusion + EGFR mutation + HER-2 mutation (1)
CRKL overexpression + EGFR mutation (1)
EGFR C797S + KRAS amplification + RB1 deletion (1)
EGFR C797S + MET amplification (1)
EGFR E746_A750del + KRAS amplification (1)
EGFR G719A + EGFR S768I + PD-L1 overexpression (1)
EGFR G719A + PD-L1 overexpression (1)
EGFR G719D + EGFR L861Q + CUX1-MET fusion (1)
EGFR L747P + PD-L1 overexpression (1)
EGFR L747_A750delinsP + MET D1228H + MET D1228N + MET D1228Y + MET Y1230H + MET amplification (1)
EGFR L858R + HER-2 amplification + PIK3CA overexpression (1)
EGFR L858R + KDR overexpression + VEGFC overexpression (1)
EGFR L858R + KRAS amplification + RB1 deletion (1)
EGFR L858R + MET amplification (1)
EGFR L858R + MET overexpression (1)
EGFR L858R + MET positive (1)
EGFR L858R + PD-L1 expression (1)
EGFR L858R + PD-L1 underexpression (1)
EGFR L858R + ROS1 fusion (1)
EGFR L858R + ROS1-ADGRG6 fusion (1)
EGFR L858R + TMB-H (1)
EGFR L858R + VEGFA-L (1)
EGFR P719A + PD-L1 overexpression (1)
EGFR T263P + EGFR L858R + MET amplification (1)
EGFR T790M + HER-2 amplification (1)
EGFR T790M + KRAS amplification + RB1 deletion (1)
EGFR T790M + MET amplification (1)
EGFR T790M + MET positive (1)
EGFR T790M + MYC amplification (1)
EGFR T790M + STRN-ALK fusion + EGFR amplification + MET amplification (1)
EGFR T790M + TMB-H (1)
EGFR V843I + KRAS G13D + AKT1 E17K + PD-L1 overexpression (1)
EGFR exon 19 deletion + ALK amplification (1)
EGFR exon 19 deletion + BRAF G464A (1)
EGFR exon 19 deletion + CCND1 overexpression (1)
EGFR exon 19 deletion + EGFR L747S (1)
EGFR exon 19 deletion + EGFR S768I (1)
EGFR exon 19 deletion + EGFR T790M + EGFR C797S + HER-2 amplification (1)
EGFR exon 19 deletion + EGFR T790M + PD-L1 expression (1)
EGFR exon 19 deletion + EGFR exon 21 mutation + TP53 mutation (1)
EGFR exon 19 deletion + LMNA-NTRK1 fusion + EGFR T790M (1)
EGFR exon 19 deletion + MET positive (1)
EGFR exon 19 deletion + MET amplification (1)
EGFR exon 19 deletion + MET amplification + MET D1228H + MET D1228N + MET D1228Y (1)
EGFR exon 19 deletion + MET amplification + MET D1228H + MET D1228N + MET D1228Y + MET Y1230C (1)
EGFR exon 19 deletion + PD-L1 underexpression (1)
EGFR exon 19 deletion + PTEN deletion + PIK3CA overexpression (1)
EGFR exon 19 deletion + RBM10 S167* (1)
EGFR exon 19 deletion + STRN-ALK fusion (1)
EGFR exon 19 deletion + TP53 mutation + CDK6 amplification + KRAS amplification (1)
EGFR exon 19 deletion + TP53 mutation + MET amplification (1)
EGFR exon 19 deletion + VEGFA-L (1)
EGFR exon 20 insertion + PD-L1 overexpression (1)
EGFR exon 20 insertion + TP53 mutation (1)
EGFR expression + KRAS G12C (1)
EGFR expression + TP53 mutation (1)
EGFR fusion + PD-L1 overexpression (1)
EGFR mutation + ALK negative + TMB-H (1)
EGFR mutation + BCL2L11 overexpression (1)
EGFR mutation + BRCA1 overexpression (1)
EGFR mutation + BRCA1 underexpression (1)
EGFR mutation + CCND1 expression + CDKN2A deletion (1)
EGFR mutation + CD73 overexpression (1)
EGFR mutation + Chr 14q31.1-q31.3 (1)
EGFR mutation + Chr 1p13.3-p13.1 (1)
EGFR mutation + EGFR amplification + MET amplification + MTAP deletion (1)
EGFR mutation + ER positive (1)
EGFR mutation + LANCL2 overexpression (1)
EGFR mutation + LINC00460 overexpression (1)
EGFR mutation + MET amplification + EGFR amplification (1)
EGFR mutation + MET amplification + TP53 mutation (1)
EGFR mutation + MET overexpression + MET amplification (1)
EGFR mutation + MET-CEP7 fusion (1)
EGFR mutation + PD-L1 elevation (1)
EGFR mutation + PD-L1 expression + TP53 mutation (1)
EGFR mutation + PD-L1 negative (1)
EGFR mutation + RBBP8 underexpression (1)
EGFR mutation + ROMO1 overexpression (1)
EGFR mutation + RPS6KB1 amplification (1)
EGFR mutation + S100A9 overexpression (1)
EGFR mutation + SYK overexpression (1)
EGFR mutation + TP53 expression (1)
EGFR mutation + TSLP underexpression (1)
EGFR mutation + TTF1 negative (1)
EGFR mutation + WNT5A expression (1)
EGFR negative + ALK negative + PD-L1 expression (1)
EGFR negative + S100A8 elevation (1)
EGFR negative + S100A9 elevation (1)
EGFR negative + SAA1 elevation (1)
EGFR negative + SAA2 elevation (1)
EGFR overexpression + BRAF V600E (1)
EGFR overexpression + BRAF mutation (1)
EGFR overexpression + KRAS 13D (1)
EGFR overexpression + KRAS mutation (1)
EGFR wild-type + ALK wild-type + NT5E overexpression + PD-L1 expression (1)
EGFR wild-type + Chr 11p11.11-q12.1 (1)
EGFR wild-type + Chr 7q31.1-q31.31 (1)
EGFR wild-type + Chr 9q21.31-q22.2 (1)
EGFR wild-type + MET amplification (1)
EGFR wild-type + MET overexpression (1)
EGFR-SEC61G fusion + EGFR amplification (1)
EGFRvIII mutation + EGFR-SEPTIN14 fusion + EGFR amplification (1)
EPHA2 expression + EGFR mutation (1)
ERCC2 positive + SYP negative + EGFR exon 21 mutation (1)
GPRC6A-RET fusion + EGFR mutation (1)
HER-2 amplification + EGFR mutation (1)
HR negative + EGFR amplification (1)
KIF5B-RET fusion + EGFR exon 19 deletion (1)
KRAS mutation + EGFR amplification (1)
MET exon 14 mutation + EGFR wild-type (1)
MET negative + EGFR mutation (1)
MET overexpression + EGFR wild-type (1)
MET positive + EGFR mutation (1)
NOTCH2-NTRK1 fusion + EGFR L858R (1)
PD-L1 underexpression + EGFR mutation (1)
PTGS2 positive + MET positive + PBK positive + EGFR mutation (1)
RBM10 deletion + EGFR mutation (1)
RBM10 underexpression + EGFR mutation (1)
ROS1 translocation + EGFR wild-type (1)
SHTN1-RET fusion + EGFR mutation (1)
SPECC1-RET fusion + EGFR mutation (1)
STRN-ALK fusion + EML4-ALK fusion + EGFR T790M (1)
TERT mutation + EGFR T790M + EGFR exon 20 insertion (1)
TLN1-RET fusion + EGFR mutation (1)
TRIM24-RET fusion + EGFR mutation (1)
TRIM33-RET fusion + EGFR mutation (1)
CALR elevation + EGFR mutation (0)
HER-2 positive + FGFR1 amplification (0)
PD-L1 underexpression + EGFR wild-type (0)
›
Related tests:
therascreen® EGFR RGQ PCR Kit (5)
therascreen® EGFR RGQ PCR Kit (5)
Associations
(13)
News
Trials
Search handles
@DrJNaidoo
@Latinamd
@PatelOncology
@StephenVLiu
@dipeshuprety4
@esinghimd
Search handles
@DrJNaidoo
@Latinamd
@PatelOncology
@StephenVLiu
@dipeshuprety4
@esinghimd
Filter by
Latest
11ms
Osimertinib is also an option- based on the UNICORN international series we participated in published @JTOonline For G719X, ORR was 47%, mPFS 8.8 months #lcsm (@Latinamd)
11 months ago
EGFR G719X
|
Tagrisso (osimertinib)
1year
2/ @LeXiuning @MDAndersonNews on EGFR mutations: ▪️EGFR mutations ~10-20% NSCLC pts in Europe/N America, & up to 50% of patients in Asia ▪️Exon 19 del & exon 21 L858R most common (~85-90%) ▪️🔑 Most frequent uncommon mutations to know: G719X, S768I, L861Q, & exon 20 insertions (@esinghimd)
1 year ago
Clinical
|
EGFR (Epidermal growth factor receptor)
|
EGFR mutation • EGFR L858R • EGFR exon 19 deletion • EGFR L861Q • EGFR G719X • EGFR S768I
over1year
Retrospective analysis of osimertinib in 50 pts with atypical #EGFR NSCLC in #JTOCRR. Median time to d/c 17.2m for L861Q, 7.8m for G719X, 1.5m for exon 20 insertion. Afatinib is the approved standard for atypical; amivantamab and mobocertinib for ex20ins. https://t.co/kQiqpEJYTZ (@StephenVLiu)
over 1 year ago
Retrospective data
|
EGFR (Epidermal growth factor receptor)
|
EGFR L861Q • EGFR G719X
|
Tagrisso (osimertinib) • Gilotrif (afatinib) • Rybrevant (amivantamab-vmjw) • Exkivity (mobocertinib)
over1year
🚨🚨 Check out our latest collaboration: #UNICORN: UNcommon EGFR mutations: International Case series on efficacy of #osimertinib in 1st liNe J Bair et al. ▶️N=60, G719X L861Q & T790M ▶️ORR 61%, mOS 24.5m. compound EGFR+ did better @EGFRResisters #lcsm https://t.co/7CqrcJpiXr (@Latinamd)
over 1 year ago
Clinical
|
EGFR (Epidermal growth factor receptor)
|
EGFR mutation • EGFR T790M • EGFR L861Q • EGFR G719X
|
Tagrisso (osimertinib)
over1year
In this multi-center, retrospective study @JTOonline for uncommon EGFR mutation (n=60), osimertinib demonstrated an ORR of 61% (44% for denovo T790M, 47% for G719X ORR & 80% for L861Q) Md PFS 9.5 mo Md DOR 17.4 mo & Md OS of 24.5 mo #LCSM @OncoAlert https://t.co/XxvURqgISg (@dipeshuprety4)
over 1 year ago
Retrospective data
|
EGFR (Epidermal growth factor receptor)
|
EGFR mutation • EGFR T790M • EGFR L861Q • EGFR G719X
|
Tagrisso (osimertinib)
over1year
Osimertinib in NSCLC w uncommon EGFR mutns @JTOonline: - 60pt retrosp study, overall ORR 66% - G719X ORR 47% mPFS 8.8m mDOR 9.1m - L861Q ORR 80% mPFS 16m mDOR 16m - de novo T790M ORR 44% mPFS 12.7m mDOR 46.2m ?⬇️ORR T790M than expected, important study https://t.co/B3kpq7AKbR (@DrJNaidoo)
over 1 year ago
EGFR (Epidermal growth factor receptor)
|
EGFR T790M • EGFR L861Q • EGFR G719X
|
Tagrisso (osimertinib)
2years
Retrospective report @Annals_Oncology from the national Network of Genomic Medicine in Germany describes 856 NSCLC cases with atypical #EGFR mutations. Includes G719X, S7681, L861Q, exon 20 insertions and rare point mutations with clinical outcomes. #LCSM https://t.co/2benHuhrA7 (@StephenVLiu)
2 years ago
Clinical data • Retrospective data
|
EGFR (Epidermal growth factor receptor)
|
EGFR mutation • EGFR exon 20 insertion • EGFR L861Q • EGFR G719X
over3years
#WCLC20 Results from the SUMMIT basket study of neratinib - specifically the #EGFR exon 18 mutant NSCLC cohort. Exon 18 accounts for about 5% of EGFR mutations, most commonly G719X. #LCSM @IASLC @OncoAlert (@StephenVLiu)
over 3 years ago
Pan tumor
|
EGFR (Epidermal growth factor receptor)
|
EGFR mutation • EGFR G719X • EGFR exon 18 mutation
|
Nerlynx (neratinib)
over3years
While there is more data for G719X with afatinib, the presence of brain mets and existence of data showing benefit of osimertinib for this and other atypical EGFR mutations would point me towards osi here (@PatelOncology)
over 3 years ago
EGFR (Epidermal growth factor receptor)
|
EGFR mutation • EGFR G719X
|
Tagrisso (osimertinib) • Gilotrif (afatinib)
Share
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login